Triple Negative Breast Cancer (TNBC) Clinical Trials
3 recruiting trials for Triple Negative Breast Cancer (TNBC). Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect...
Sponsor: A2 Biotherapeutics Inc.Enrolling: 20016 locations
RECRUITINGNCT06431100
a Single-arm, Single-center, Open Clinical Study
This trial plans to enroll many patients with advanced solid tumors to complete GK01 cell transfusion, including but not limited to advanced gastric cancer, esophageal cancer,...
Sponsor: Beijing Geekgene Technology Co., LTDEnrolling: 101 location
RECRUITINGPhase 1NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced...
Sponsor: Nurix Therapeutics, Inc.Enrolling: 34517 locations